An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells. (2020)

First Author: Gill MR
Attributed to:  University of Oxford Confidence in Concept Scheme – Round 4 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d0sc02825h

PubMed Identifier: 33815738

Publication URI: http://europepmc.org/abstract/MED/33815738

Type: Journal Article/Review

Volume: 11

Parent Publication: Chemical science

Issue: 33

ISSN: 2041-6520